White Plains, New York, 10604, United States
NCT Number: NCT00407914
Safety and Effectiveness of Aquamid as Compared to Restylane for the Aesthetic Treatment of Nasolabial Folds
The purpose of this study is to compare the effectiveness of Aquamid and Restylane in aesthetically enhancing nasolabial folds 6 months after treatment and to evaluate the safety of Aquamid through 12 months after treatment.
The study includes an extended follow up to 24 months.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- interested on soft tissue augmentation for the nasolabial folds
- moderate to severe nasolabial fold
Exclusion criteria
- sensitivity to anesthetics
- allergy to hyaluronic acid
- previous treatment with permanent fillers in the treated area
- recent previous aesthetic procedure in the treatment area
- infected skin areas or autoimmune diseases affecting the skin
Treatment and study plan
Aquamid
DeviceSubcutaneous injection
Restylane
DeviceInjection in dermis
Primary outcomes
-
Wrinkle Assessment Scale
Time frame: Baseline, 3, 6, 9, 12 Months
-
Adverse device effects
Time frame: continuosly
Secondary outcomes
-
Global Aesthetic Improvement Scale
Time frame: Optimal treatment, 3, 6, 9 and 12 Months
-
Injection site reactions
Time frame: After injection
-
Adverse events
Time frame: continuosly
Sponsors and collaborators
Lead sponsor
Contura
Industry
Registry information
Official study title
A Double-Masked, Randomized, Multi-Center, 2-Arm Parallel Study Comparing the Safety and Effectiveness of Aquamid and Restylane for the Aesthetic Treatment of Nasolabial Folds
Important dates
- Study start
- 2006
- Primary completion
- 2008
- Study completion
- 2009
- First posted
- Dec 5, 2006
- Registry last updated
- Oct 8, 2009
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Study of the Subdermal Implant "Algeness"
NCT07618468
Facial Wrinkles, Lipid Metabolism Disorders
Moscow, Russia
View Trial DetailsStudy of the Subdermal Implant "Ultracol"
NCT07617350
Facial Lipoatrophy, Facial Wrinkles
Moscow, Russia
View Trial DetailsClinical Study Evaluating the Safety and Effectiveness of the NIRA Laser M2.1 for the Treatment of Full-Face Wrinkles
NCT07572331
Acne, Acne Vulgaris
Beverly, Massachusetts, United States
View Trial DetailsSafety and Efficacy Evaluation of the Monopolar Radiofrequency Device for the Improvement of Facial Wrinkles
NCT06657365
Anti-Aging, Facial Wrinkles
Beijing, China
View Trial Details